Neuren Pharmaceuticals Ltd
ASX:NEU

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
ASX:NEU
Watchlist
Price: 12.2 AUD -0.08% Market Closed
Market Cap: 1.6B AUD
Have any thoughts about
Neuren Pharmaceuticals Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Neuren Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: AUD
Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Operating Cash Flow
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
(12)
(44)
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(1)
(3)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
0
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
1
0
(1)
(2)
0
6
Cash from Operating Activities
(9)
N/A
(10)
-13%
(11)
-14%
(12)
-6%
(9)
+25%
(4)
+51%
(1)
+71%
(1)
-13%
(3)
-106%
(2)
+19%
(3)
-30%
(3)
+15%
(3)
-9%
(5)
-74%
(7)
-41%
(7)
-3%
(6)
+12%
(8)
-31%
(13)
-51%
(17)
-30%
(12)
+25%
(8)
+39%
(6)
+26%
(4)
+29%
6
N/A
2
-61%
(12)
N/A
(9)
+23%
(8)
+10%
(9)
-12%
(10)
-10%
(10)
+3%
4
N/A
54
+1 409%
185
+241%
120
-35%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
0
0
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(47)
(211)
(163)
Cash from Investing Activities
(0)
N/A
(0)
-43%
(0)
+90%
0
N/A
0
-80%
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
-50%
(0)
+67%
(0)
N/A
(0)
-200%
(0)
N/A
(0)
+67%
0
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
(0)
+50%
(0)
N/A
(0)
-33%
(0)
-25%
(0)
-20%
(0)
-58%
(47)
-248 916%
(211)
-347%
(163)
+23%
Financing Cash Flow
Net Issuance of Common Stock
7
7
0
7
10
3
2
3
0
1
9
7
0
1
27
28
2
2
8
7
1
0
5
11
12
3
0
0
20
20
23
0
0
1
4
4
Net Issuance of Debt
0
0
3
3
(0)
(0)
1
1
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
(0)
(0)
(0)
(1)
(1)
0
1
0
(0)
0
0
(0)
(0)
(0)
(1)
(1)
(0)
0
(0)
0
(0)
(0)
(0)
(0)
(0)
0
2
0
(1)
0
(1)
(1)
(0)
(0)
(0)
(0)
Cash from Financing Activities
7
N/A
7
+0%
3
-53%
10
+190%
9
-6%
3
-65%
3
+8%
4
+11%
1
-67%
3
+124%
9
+221%
7
-20%
0
-94%
1
+21%
26
+5 031%
27
+2%
2
-92%
2
-1%
8
+246%
7
-14%
1
-86%
1
-16%
5
+591%
11
+99%
12
+11%
3
-77%
2
-31%
0
-76%
19
+4 270%
19
-1%
22
+17%
22
0%
(0)
N/A
1
N/A
4
+230%
4
+15%
Change in Cash
Effect of Foreign Exchange Rates
0
(1)
0
0
0
0
(0)
(0)
(0)
(0)
0
0
(0)
0
0
(0)
1
1
1
0
(0)
(0)
(0)
0
1
1
0
0
(1)
(1)
0
0
(0)
(1)
(0)
4
Net Change in Cash
(2)
N/A
(4)
-150%
(8)
-101%
(2)
+75%
0
N/A
(1)
N/A
2
N/A
2
+10%
(2)
N/A
0
N/A
6
+4 221%
5
-23%
(3)
N/A
(4)
-65%
19
N/A
19
-1%
(4)
N/A
(5)
-35%
(4)
+13%
(10)
-128%
(12)
-22%
(7)
+41%
(0)
+95%
7
N/A
19
+182%
6
-69%
(10)
N/A
(8)
+17%
10
N/A
9
-13%
13
+39%
13
+2%
3
-74%
7
+115%
(23)
N/A
(36)
-55%
Free Cash Flow
Free Cash Flow
(9)
N/A
(10)
-14%
(12)
-13%
(12)
-5%
(9)
+25%
(4)
+51%
(1)
+71%
(1)
-13%
(3)
-107%
(2)
+18%
(3)
-30%
(3)
+15%
(3)
-10%
(5)
-72%
(7)
-40%
(7)
-3%
(6)
+12%
(8)
-31%
(13)
-51%
(17)
-30%
(12)
+25%
(8)
+39%
(6)
+26%
(4)
+29%
6
N/A
2
-61%
(12)
N/A
(9)
+24%
(8)
+10%
(9)
-12%
(10)
-10%
(10)
+3%
4
N/A
54
+1 416%
185
+241%
119
-35%

See Also

Discover More